Back to Search
KLAUS HOLLMIG, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1083704563Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
P3001(TX)MD153666(OR)
Research & Publications (20)
Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival.
PMID 19389881·Blood·2009
8-other
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols.
PMID 19515721·Blood·2009
3-trial
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
PMID 18492953·Blood·2008
3-trial
Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma.
PMID 18470907·Cancer·2008
8-other
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
PMID 17895401·Blood·2008
8-other
Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease.
PMID 18669874·Blood·2008
3-trial
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
PMID 17105813·Blood·2007
8-other
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
PMID 17023574·Blood·2007
8-other
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
PMID 17156398·Br J Haematol·2007
2-rct
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
PMID 18056185·Clin Cancer Res·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-4673
Quick Facts
- NPI
- 1083704563
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile